These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35420510)

  • 1. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
    Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
    Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer screenings during the COVID-19 pandemic: An analysis of public interest trends.
    Greiner B; Tipton S; Nelson B; Hartwell M
    Curr Probl Cancer; 2022 Feb; 46(1):100766. PubMed ID: 34304883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
    Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
    JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 pandemic on cancer screenings in Portugal.
    Mendes D; Figueiredo D; Alves C; Penedones A; Costa B; Batel-Marques F
    Cancer Epidemiol; 2024 Feb; 88():102496. PubMed ID: 38061274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
    Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
    BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
    Kinslow CJ; DeStephano DM; Neugut AI; Taparra K; Horowitz DP; Yu JB; Cheng SK
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer mortality surveillance--United States, 1990-2000.
    Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA
    MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy.
    Schoenborn NL; Huang J; Sheehan OC; Wolff JL; Roth DL; Boyd CM
    J Gen Intern Med; 2019 Jan; 34(1):110-117. PubMed ID: 30402822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects.
    Fisher-Borne M; Isher-Witt J; Comstock S; Perkins RB
    Prev Med; 2021 Oct; 151():106681. PubMed ID: 34217422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters.
    London JW; Fazio-Eynullayeva E; Palchuk MB; Sankey P; McNair C
    JCO Clin Cancer Inform; 2020 Jul; 4():657-665. PubMed ID: 32716647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
    Machii R; Takahashi H
    Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center.
    Lou J; Kooragayala K; Williams JP; Sandilos G; Butchy MV; Yoon-Flannery K; Kwiatt M; Hong YK; Shersher DD; Burg JM
    Am J Clin Oncol; 2022 Sep; 45(9):381-390. PubMed ID: 35983965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
    Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
    Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.